News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zonagen (ZONA) Reports Third Quarter 2005 Financial Results And Provides Update On Proellex And Androxal Clinical Development Programs


11/11/2005 1:43:51 PM

THE WOODLANDS, Texas--(BUSINESS WIRE)--Nov. 11, 2005--Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA) today reported financial results for the three-month and nine-month periods ended September 30, 2005 and provided an update on its clinical development efforts for Proellex(TM) and Androxal(TM).

Read at BioSpace.com

Related News

comments powered by Disqus
Zonagen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES